| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 7, 2026 | ±3.1% | -1.4% | over-priced |
| November 6, 2025 | ±2.0% | +0.2% | over-priced |
| August 7, 2025 | ±2.0% | +0.3% | over-priced |
| May 8, 2025 | ±2.1% | +0.9% | over-priced |
| November 7, 2024 | ±2.3% | -0.6% | over-priced |
| August 7, 2024 | ±3.3% | -0.6% | over-priced |
| May 2, 2024 | ±2.1% | +0.7% | over-priced |
| November 2, 2023 | ±2.7% | +3.3% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.11 | $48.6B | $2.3B |
| Q4 FY2025 | $1.36 | $46.9B | $2.8B |
| Q3 FY2025 | $1.82 | $49.7B | $3.6B |
| Q2 FY2025 | $1.45 | $44.8B | $2.5B |
Chevron Corporation (CVX) reports in 99 days, with the next report estimated for September 20, 2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced CVX's earnings risk. Fundamentals into the print: EPS down 44.5% year-over-year, revenue up 2.1%. QuantLogix's live 5-factor engine currently reads CVX as a buy at 59/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →